Table 1.
Population group | Population type | Year, midpoint | Diagnostic test | N positive | N tested | Prevalence (%) | Weight (%) | Location/Sites | Source |
---|---|---|---|---|---|---|---|---|---|
Lower-risk women | ANC: Survey | 2005 | RPR & TPHA | 4 | 3,242 | 0.12 | 25 | 4 national surveillance sites within Yunnan province (Kunming, Qilin, Longyang and Gejiu) | 16 |
2006 | 15 | 3,241 | 0.46 | 25 | |||||
2007 | 3 | 2,702 | 0.11 | 25 | |||||
2008 | 12 | 3,215 | 0.37 | 25 | |||||
2009 | 0 | 3,041 | 0.00 | 25 | |||||
2010 | 4 | 1,599 | 0.25 | 25 | |||||
2011 | 5 | 1,600 | 0.31 | 25 | |||||
2012 | 5 | 1,600 | 0.31 | 25 | |||||
2013 | 1 | 1,600 | 0.06 | 25 | |||||
2014 | 9 | 1,600 | 0.56 | 25 | |||||
2015 | 4 | 1,600 | 0.25 | 25 | |||||
2016 | 6 | 1,600 | 0.38 | 25 | |||||
2017 | 6 | 1,596 | 0.38 | 25 | |||||
ANC: Routine screening | 2011 | RPR & TPHA | 239 | 637,241 | 0.04 | 0 | All 16 prefectures and 129 counties | 2 | |
2012 | 690 | 786,334 | 0.09 | 0 | |||||
2013 | 1,032 | 753,696 | 0.14 | 0 | |||||
2014 | 1,338 | 761,945 | 0.18 | 0 | |||||
2015 | 1,360 | 730,474 | 0.19 | 99.66 | |||||
2016 | 1,879 | 888,171 | 0.21 | 99.92 | (Unpublished) program data, Yunnan CDC, Kunming, Yunnan | ||||
2017 | 1,974 | 814,401 | 0.24 | 99.95 | |||||
Blood Donor Screening | 2008 | TPHA alone | 120 | 29,584 | 0.41 | 43.75 | 7 prefectures (Chuxiong, Nujiang, Wenshan, Xishuangbanna, Yuxi, Diqing and Qujing) | 17,18 | |
2009 | 132 | 32,465 | 0.41 | 43.75 | |||||
2010 | 139 | 34,310 | 0.41 | 43.75 | |||||
2011 | 141 | 35,771 | 0.39 | 43.75 | |||||
2012 | 165 | 39,956 | 0.41 | 43.75 | |||||
2013 | 159 | 38,165 | 0.42 | 43.75 | |||||
2014 | 142 | 42,835 | 0.33 | 43.75 | |||||
2015 | 179 | 45,849 | 0.39 | 43.75 | |||||
2016 | 241 | 52,006 | 0.46 | 43.75 | |||||
2017 | 238 | 55,471 | 0.43 | 43.75 | |||||
Premarital Screening | 2001 | TPHA alone | 24 | 3,742 | 0.34 | 6.25 | 1 site (urban and rural) | 19 | |
Lower-risk men | Blood Donor Screening | 2008 | TPHA alone | 217 | 43,020 | 0.50 | 43.75 | 7 prefectures (Chuxiong, Nujiang, Wenshan, Xishuangbanna, Yuxi, Diqing and Qujing) | 17,18 |
2009 | 244 | 47,547 | 0.51 | 43.75 | |||||
2010 | 220 | 52,385 | 0.42 | 43.75 | |||||
2011 | 229 | 56,517 | 0.41 | 43.75 | |||||
2012 | 297 | 62,171 | 0.48 | 43.75 | |||||
2013 | 236 | 56,320 | 0.42 | 43.75 | |||||
2014 | 252 | 61,675 | 0.41 | 43.75 | |||||
2015 | 275 | 65,825 | 0.42 | 43.75 | |||||
2016 | 339 | 73,984 | 0.46 | 43.75 | |||||
2017 | 317 | 76,685 | 0.41 | 43.75 | |||||
Premarital Screening | 2001 | TPHA alone | 24 | 3,742 | 0.34 | 6.25 | 1 site (urban and rural) | 19 | |
Lower-risk Women + Men pooled | Blood Donor Screening | 2008 | TPHA alone | 39 | 9,102 | 0.43 | 6.25/0* | 1 prefecture (Dehong) | 20 |
2009 | 29 | 10,034 | 0.29 | 6.25/0* | |||||
2010 | 36 | 11,622 | 0.31 | 6.25/0* | |||||
2011 | 35 | 13,302 | 0.26 | 6.25/0* | |||||
2012 | 53 | 13,164 | 0.40 | 6.25/0* | |||||
2013 | 39 | 12,295 | 0.32 | 6.25/0* | |||||
FSW | FSW: Study | 2006 | RPR & TPHA | 55 | 737 | 7.46 | 10 | 1 site (Kaiyuan City) | 21 |
FSW: Study | 2006 | RPR & TPHA | 12 | 96 | 12.50 | 20 | 2 sites (Kafang & Laochang towns) | 50 | |
FSW: Study | 2007 | RPR & TPHA | 27 | 397 | 6.80 | 10 | 1 site (Kaiyuan City) | 26 | |
FSW: Study | 2007 | RPR & TPHA | 32 | 270 | 11.85 | 10 | Detaining education centre, urban | 28 | |
FSW | FSW: Study | 2010.5 | RPR & TPHA | 3 | 201 | 1.49 | 10 | 1 site (Kaiyuan City) | 27 |
FSW: Study | 2011 | RPR & TPHA | 113 | 1,775 | 6.37 | 10 | 1 site (Kaiyuan City) | 53 | |
FSW: Study | 2012 | RPR & TPHA | 62 | 734 | 8.45 | 10 | 1 site (Kaiyuan City) | 23 | |
FSW: Study | 2012.5 | RPR & TPHA | 44 | 225 | 19.56 | 40 | 4 sites (Dali, Jinghong, Kaiyuan and Menghai cities) | 24 | |
FSW: Study | 2017 | RPR & TPHA | 13 | 423 | 3.07 | 10 | 1 site (Kunming City) | 29 | |
FSW: Sentinel | 2005 | RPR & TPHA | 107 | 5,849 | 1.83 | 100 | All 16 prefectures | 16 | |
2006 | 50 | 5,396 | 0.93 | 100 | |||||
2007 | 92 | 5,782 | 1.59 | 100 | |||||
2008 | 77 | 5,909 | 1.30 | 100 | |||||
2009 | 71 | 6,225 | 1.14 | 100 | |||||
2010 | 135 | 5,960 | 2.27 | 100 | |||||
2011 | 113 | 6,026 | 1.88 | 100 | |||||
2012 | 146 | 6,047 | 2.41 | 100 | |||||
2013 | 88 | 6,464 | 1.36 | 100 | |||||
2014 | 68 | 5,495 | 1.24 | 100 | |||||
2015 | 54 | 5,836 | 0.93 | 100 | |||||
2016 | 104 | 6,336 | 1.64 | 100 | |||||
MSM | MSM: Sentinel | 2010 | RPR & TPHA | 44 | 1,169 | 3.76 | 87.5 | 14 prefectures | 16 |
2011 | 21 | 1,556 | 1.35 | 87.5 | |||||
2012 | 65 | 2,613 | 2.49 | 87.5 | |||||
2013 | 83 | 2,992 | 2.77 | 87.5 | |||||
2014 | 91 | 3,206 | 2.84 | 87.5 | |||||
2015 | 103 | 2,983 | 3.45 | 87.5 | |||||
2016 | 106 | 2,863 | 3.70 | 87.5 | |||||
MSM: Study | 2009 | TPHA alone | 62 | 825 | 7.52 | 10 | 1 site (Kunming City) | 30 | |
MSM: Study | 2010 | RPR & TPHA | 6 | 305 | 1.97 | 10 | 1 site (Dali prefecture) | 33 | |
MSM: Study | 2014 | RPR & TPHA | 34 | 300 | 11.33 | 10 | 1 site (Kunming City) | 32 | |
MSM: Study | 2008 | RPR & TPHA | 37 | 266 | 13.91 | 10 | 1 site (Kunming City) | 31 | |
2009 | 40 | 307 | 13.03 | 10 | |||||
2010 | 36 | 258 | 13.95 | 10 |
Pre-2015 ANC routine screening data were not included in the default estimation owing to a change in the ANC screening algorithm in 2015 from Treponema pallidum particle agglutination assay (TPPA) and RPR with an RPR threshold of 1:8, to a positive result from a Treponema-based rapid point-of-care test followed by RPR confirmation with no threshold, and an expansion in the number of sites tested from 2011 to 2015.
A number of the studies in FSW venues were cohort studies with repeated measurements and where later rounds probably resampled the same individuals after they had been treated. For these studies only the 1st round of data were included in the Spectrum estimations.
*6.25% is the default weight for men. These data were not included in default the estimate for women, owing to the large number of other women-specific data points.
Abbreviations: RPR = Rapid Plasma Reagin test; TPHA = Treponema pallidum hemagglutination assay; RPR&TPHA = dual positivity on both RPR and TPHA.